Copyright © 2019. Inderes Oy. All rights reserved.
Search
User account

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

Log in
Nexstim
2448 investors follow this company
The company is not covered. See all listed companies from here.
BUY 0.08 LOWEST 0.08 VOLUME 41 801
SELL 0.08 HIGHEST 0.08 VALUE 0,003 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Upcoming events

28
Feb
Tilinpäätöstiedotteet

Latest insider trading

Type: stock_exchange_release
24.2.
2020

Company announcement, Helsinki, 24 February 2020 at 9.00 am (EET)

Notice of Nexstim Plc 2019 Full Year Results

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") will announce its full year results for the year ended 31 December 2019 on Friday 28 February 2020 at 9.00 am Finnish time.

Type: stock_exchange_release
18.2.
2020

Press Release, Helsinki, 18 February 2020 at 10.30 am (EET)

Two Nexstim TMS systems with SmartFocus® technology installed in Italy

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has sold and installed two TMS systems with SmartFocus® TMS technology to two leading neuroscience institutions in Italy.

Type: stock_exchange_release
11.2.
2020

Company announcement, Inside information, Helsinki, 11 February 2020 at 9:05 AM (EET)

Change in Nexstim Plc's Management Team – Joonas Juokslahti appointed as interim CFO

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Board of Directors has appointed Joonas Juokslahti (born 1986) as interim CFO with immediate effect.

Joonas Juokslahti joined Nexstim in May 2014 as Business Controller and has been a key part of the Nexstim finance team especially in his latest position as Finance Manager.

Type: stock_exchange_release
11.2.
2020

Company announcement, Inside information, Helsinki, 11 February 2020 at 9:00 AM (EET)

Nexstim Plc’s CEO changes - Mikko Karvinen appointed as interim CEO

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Martin Jamieson has decided to leave his positions as the CEO of the Company and as a member of the Board of Directors of Nexstim, effective immediately.

Nexstim's Board of Directors has appointed Mikko Karvinen (born 1976) as interim CEO. He has worked as Nexstim’s CFO since August 2014.

Type: stock_exchange_release
4.2.
2020

Press Release, Helsinki, 4 February 2020 at 11.15 am (EET)

Nexstim NBT® System with SmartFocus® TMS installed at Mind Matters PsychiatryMD, US

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that an NBT® System with SmartFocus® TMS technology has been installed at Mind Matters PsychiatryMD in Texas, US.

Mind Matters PsychiatryMD evaluates and treats psychiatric disorders in three different locations in Texas. They provide a variety of treatment options, including transcranial magnetic stimulation (TMS).

Type: stock_exchange_release
16.1.
2020

Company announcement, Helsinki, 16 January 2020 at 1.30 PM (EET)

Nexstim Plc‘s Technology Licencing Discussions Ended with a Leading California Based Academic Institution

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announced on October 2, 2019 that it had entered in licensing negotiations with a leading California based academic institution.

Type: stock_exchange_release
23.12.
2019

Company announcement, Helsinki, 23 December 2019 3.00 pm (EET)

Nexstim Plc’s Financial Information in 2020

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will publish the following financial information in 2020:

The 2019 Financial Statements Release and Half-Yearly Report July−December 2019 (H2) on Friday, February 28, 2020. Half-Yearly Report January-June 2020 (H1) on Friday, August 14, 2020.

Type: stock_exchange_release
18.12.
2019

Company announcement, insider information, Helsinki, 18 December 2019 at 9.00 am (EET)

Nexstim Plc’s Board of Directors resolved on a directed share issue of approximately 141 thousand euro to Kreos Capital V (UK) Limited

Type: stock_exchange_release
5.12.
2019

 Company announcement, Helsinki, 5 December 2019 at 11.10 am (EET)

Nexstim Plc: Health Canada Grants Nexstim NBT® Medical Device License for Canada

Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that its NBT® System with SmartFocus® TMS technology has received a medical device license from Health Canada.

The medical device license allows Nexstim to start marketing and commercial distribution of the NBT® system for the treatment of Major Depressive Disorder (MDD) in Canada.

Type: stock_exchange_release
2.12.
2019

Press Release, Helsinki, 2 December 2019 at 10 am (EET)

Nexstim NBT® System with SmartFocus® TMS installed at Rockford Psychiatric Medical Services, US

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Rockford Psychiatric Medical Services has started using Nexstim NBT® System with SmartFocus® TMS technology.

Nexstim

English translation unavailable for Nexstim.
Nexstim lyhyesti